Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Hyperammonemia Induced by Interaction of Valproate and Quetiapine

Author(s): Athar Halaby, Ramzi Haddad and Wadih J. Naja

Volume 8, Issue 4, 2013

Page: [284 - 286] Pages: 3

DOI: 10.2174/15748863113089990039

Price: $65

Abstract

Introduction: Hyperammonemia is one of the rare nevertheless serious side effects associated with valproic acid treatment. Two cases of valproic acid induced hyperammonemia are detailed in this article.

Cases: Case one describes an adult male who developed hyperammonemia after acute exposure to valproic acid as a treatment for his bipolar disorder-manic episode. Case two developed a similar pattern of toxicity but after chronic exposure to valproic acid. Both patients were receiving a combination of valproic acid and quetiapine.

Discussion: Measurement of the ammonium level should be considered where there is a decreased level of consciousness in patients receiving valproic acid irrespective of the diagnosis and even after a long term exposure. A possible risk of hyperammonemia can result from a combination of valproic acid and quetiapine, however further studies are yet needed to confirm this hypothesis.

Keywords: Hyperammonemia, quetiapine, valproic acid.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy